{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:31:05Z","timestamp":1775183465916,"version":"3.50.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Empyema is the most common complication of pediatric community-acquired pneumonia, posing a significant morbidity to children. Clinicians have observed an increase in empyema rates and acuity in the years following the COVID-19 pandemic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This retrospective analysis of children managed for empyema in a tertiary pediatric hospital, aimed to compare the incidence and describe the clinical characteristics prepandemic and postpandemic (2017\u20132023).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>There were 222 empyema cases, with a median age of 3 years (0.3\u201315 years). The majority (87.8%) of cases were managed with a chest drain and fibrinolytics. The remaining underwent minimally invasive video-assisted thoracoscopic surgery. Admissions postpandemic were associated with significantly longer lengths of stays (14 vs 12 days, <jats:italic toggle=\"yes\">P<\/jats:italic> \u2264 0.001), higher rates of pediatric intensive care unit admissions (32% vs 26%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.045), and they required higher level of care (inotropes, noninvasive and invasive ventilation). There were also significantly higher rates of <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic> (28% vs 7%, <jats:italic toggle=\"yes\">P<\/jats:italic> \u2264 0.001), while rates of other organisms were not significantly different. We also noted a significant reduction in immunization rates post-pandemic (95.8% vs 83.1%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01); however, there was no significant difference in <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic> serotypes between epochs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study demonstrates an increased rate and severity of pediatric empyemas in the post-pandemic period. We propose that the increase was secondary to the increased rates of <jats:italic toggle=\"yes\">S. pyogenes<\/jats:italic> seen in the postpandemic period. This rise in infection rates may be alleviated with nonpharmacologic measures aimed at reducing transmission; however, such measures are not sustainable and should be avoided.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004544","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T16:00:39Z","timestamp":1726070439000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["An Australian Single-center Cohort of Pediatric Empyema: Incidence, Pathogens and Disease Severity, and the Interaction of the COVID-19 Pandemic"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7456-1006","authenticated-orcid":false,"given":"Emily R.","family":"Le Fevre","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, The Children\u2019s Hospital at Westmead, Locked Bag, Westmead, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiran","family":"Selvadurai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Children\u2019s Hospital at Westmead, Locked Bag, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Haggie","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Children\u2019s Hospital at Westmead, Locked Bag, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"R1-20250721","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/thoraxjnl-2012-203026","article-title":"British thoracic society paediatric pneumonia audit: a review of 3 years of data.","volume":"68","author":"Bowen","year":"2013","journal-title":"Thorax"},{"key":"R2-20250721","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamapediatrics.2019.5863","article-title":"Effectiveness of intrapleural tissue plasminogen activator and dornase alfa vs tissue plasminogen activator alone in children with pleural empyema: a randomized clinical trial.","volume":"174","author":"Livingston","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R3-20250721","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0972-9941.38908","article-title":"Thoracoscopic management of empyema thoracis.","volume":"3","author":"Wait","year":"2007","journal-title":"J Minim Access Surg"},{"key":"R4-20250721","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/archdischild-2019-318219","article-title":"Paediatric empyema: worsening disease severity and challenges identifying patients at increased risk of repeat intervention.","volume":"105","author":"Haggie","year":"2020","journal-title":"Arch Dis Child"},{"key":"R5-20250721","first-page":"42","article-title":"Management of paediatric empyema by video-assisted thoracoscopic surgery (VATS) versus chest drain with fibrinolysis: Systematic review and meta-analysis.","volume":"30","author":"Pacilli","year":"2019","journal-title":"Paediatr Respir Rev"},{"key":"R6-20250721","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1097\/INF.0000000000003503","article-title":"Staphylococcus aureus community-acquired pneumonia in children after 13-valent pneumococcal vaccination (2008-2018): epidemiology, clinical characteristics and outcomes.","volume":"41","author":"Aguilera-Alonso","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20250721","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/archdischild-2015-309831","article-title":"When should clinicians suspect group A streptococcus empyema in children? a multicentre case-control study in French tertiary care centres.","volume":"101","author":"Bellulo","year":"2016","journal-title":"Arch Dis Child"},{"key":"R8-20250721","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study.","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R9-20250721","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1473-3099(23)00008-7","article-title":"National case series of group A streptococcus pleural empyema in children: clinical and microbiological features.","volume":"23","author":"Holdstock","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"R10-20250721","first-page":"100873","article-title":"Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges.","volume":"41","author":"Abo","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R11-20250721","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/INF.0000000000002474","article-title":"Increasing rates of pediatric empyema and disease severity with predominance of serotype 3 S. pneumonia: an Australian single-center, retrospective cohort 2011 to 2018.","volume":"38","author":"Haggie","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20250721","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/jpc.15905","article-title":"Characteristics, management and changing incidence of children with empyema in a paediatric intensive care unit.","volume":"58","author":"Subhi","year":"2022","journal-title":"J Paediatr Child Health"},{"key":"R13-20250721"},{"key":"R14-20250721","doi-asserted-by":"crossref","first-page":"ofad188","DOI":"10.1093\/ofid\/ofad188","article-title":"Unexpected increase in invasive group A streptococcal infections in children after respiratory viruses outbreak in France: a 15-year time-series analysis.","volume":"10","author":"Lassoued","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R15-20250721","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?.","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"},{"key":"R16-20250721","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm1077","article-title":"A role for streptococcus pneumoniae in virus-associated pneumonia.","volume":"10","author":"Madhi","year":"2004","journal-title":"Nat Med"},{"key":"R17-20250721","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/ijerph16061078","article-title":"Association of consecutive influenza vaccinations and pneumonia: a population-based case-control study.","volume":"16","author":"Yeh","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"R18-20250721","doi-asserted-by":"crossref","first-page":"576519","DOI":"10.3389\/fped.2020.576519","article-title":"Outcome of severe bacterial pneumonia in the era of pneumococcal vaccination.","volume":"8","author":"Del Rosal","year":"2020","journal-title":"Front Pediatr"},{"key":"R19-20250721","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009.","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"R20-20250721","doi-asserted-by":"crossref","first-page":"106242","DOI":"10.1016\/j.jinf.2024.106242","article-title":"Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes.","volume":"89","author":"Silva-Costa","year":"2024","journal-title":"J Infect"},{"key":"R21-20250721","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/genes10110845","article-title":"Evolution of streptococcus pneumoniae serotype 3 in England and Wales: a major vaccine evader.","volume":"10","author":"Groves","year":"2019","journal-title":"Genes (Basel)"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T19:00:12Z","timestamp":1753124412000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004544","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}